Abstract
Chromatography of human myeloperoxidase (MPO) on a heparin-agarose column demonstrated a tight association of the protein with the resin. The electrophoretic mobility of mixtures of MPO and heparin in polyacrylamide gels under nondenaturing conditions was consistent with a strong interaction of the cationic enzyme with the polyanionic polysaccharide. Purified MPO prebound to bovine aorta endothelial cells (BAEC) and supplemented with hydrogen peroxide dose- and time-dependently abrogated the interaction of coagulation factor IX (FIX) with factor IX-binding protein (FIXBP) on the surface of BAEC reflecting oxidative modification of the binding protein. This inactivation of FIXBP required the presence of chloride implicating hypochlorite in the reaction. Hypochlorite and activated neutrophils exerted a similar effect. The oxidative modification of FIXBP was only partially dependent on the addition of hydrogen peroxide and was abolished by exogenous heparin which displaced MPO from the cell surface, emphasizing the functional differences between cell-bound and free enzyme.
Similar content being viewed by others
References
Harlan JM: Leucocyte-endothelial interactions. Blood 65: 513–525, 1985
Babior BM: Oxidants from phagocytes: Agents of defense and destruction. Blood 64: 959–966, 1984
Badwey JA, Karnovsky MJ: Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 49: 63–706, 1980
Klebanoff SJ: Oxygen metabolites from phagocytes. In: JI Gallin, IM Goldstein, R Snyderman (eds). Inflammation: Basic Principles and Clinical Correlated (2nd edition), Raven Press Ltd., New York, 1992, pp 541–588
Elsbach P, Weiss J: Oxygen-independent antimicrobial systems of phagocytes. IM Goldstein, R Snyderman (eds). Inflammation: Basic Principles and Clinical Correlated (2nd edition), Raven Press Ltd., New York, 1992 ibid., pp 603–636
Henson PM, Johnston RB Jr: Tissue injury in inflammation. J Clin Invest 79: 669–674, 1987
Harrison JE, Pabalan S, Schultz J: Subunit structure of crystalline canine myeloperoxidase. Biochim Biophys Acta 493: 247–259, 1977
Agner K: Biological effects of hypochlorus acid formed by MPO. In: A Akeson, A Ehrenberg (eds). Structure and Function of Oxidation Reduction Enzymes, Vol. 18, Pergamon Press, New York, 1972, pp 329–334
Heinecke JW, Li W, Daehnke III HL, Goldstein JA: Dityrosine, a specific marker of oxidation is synthesized by the myeloperoxidasehydrogen peroxide system of human neutrophils and macrophages J Biol Chem 268: 4069–4077, 1993
Johnson RJ, Couser WG, Chi EY, Adler S, Kelbanoff SJ: New mechanism for glomerular injury. J Clin Invest 79: 1379–1387, 1987
Dougherty A, Rateri DL, Dunn J, Heinecke J: Myeloperoxidase, a catalyst for lipoprotein oxidation is expressed in human atherosclerotic lesions. J Clin Invest 94: 437–444, 1994
Marcum JA, Atha DH, Fritze LMS, Nawroth P, Stern D, Rosenberg RD: Cloned bovine aorta endothelial cells synthesizes anticoagulantly active heparan sulfate proteoglycans. J Biol Chem 261: 7507–7517, 1986
Kjellen L, Lindahl U: Proteoglycans: Structure and interactions. Ann Rev Biochem 60: 443–447, 1992
Zhou F, Hook T, Thompson JA, Hook M: Heparin-protein interactions. In: DE Lane et al. (eds). Heparin and Related Polysaccharides, Plenum Press, New York, 1992 pp 141–153
Rimon S, Melamid R, Savion N, Scott T, Nawroth PP, Stern D: Identification of Factor IX/IXa-binding protein on endothelial cells surface. J Biol Chem 262: 6023–6029, 1987
Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest (suppl) 97: 77–89, 1968
Schwartz SM: Selection and characterization of bovine aortic cells. In Vitro 14: 966–980, 1978
Chopra J, Joist JH, Webster RO: Loss of 51chromium, lactate dehydrogenase and 111indium as indicators of endothelial cells injury. Lab Invest 57: 578–584, 1987.
Andrews PC, Krinsky NI: The reductive cleavage of myeloperoxidase in half, producing enzymatically active myeloperoxidase. J Biol Chem 255: 4211–4218, 1980
Bakkenist ARJ, Wever R, Vulma T, Plat H, Van Gelder BF: Isolation procedure and some properties of myeloperoxidase from human leukocytes. Biochim Biophys Acta 524: 45–54, 1978
Babior BM, Cohen HJ: In: MJ Cline (ed). Measurement of Neutrophil Function: Phagocytosis, Degranulation, the Respiratory Burst and Bacterial Killing. Meth Haematol. 3, Leukocyte Function, 1981, pp 1–38
David GS, Reisfeld RA: Protein iodination with solid state lactoperoxidase. Biochemistry 13: 1014–1021, 1979
Thomas JM, Hoades ME: A new discontinuous buffer system for the electrophoresis of cationic proteins at near neutral pH. Anal Biochem 118: 194–196, 1981
Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (London) 227: 680–685, 1970
Sundquist T: Bovine aortic endothelial cells release hydrogen peroxide. J Cell Physiol 148: 152–156, 1991
Matsubara T, Ziff M: Increased superoxide anion release from human endothelial cells: Synergism between a phorbol ester and a calcium ionophore. J Cell Physiol 127: 207–210, 1986
Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang TJ, Lin J-H, Vilander L, Andrews WH, Light DR: Oxidation of specific residue in thrombomodulin by activated neutrophil products blocks cofactor activity. J Clin Invest 90: 2565–2573, 1992
Savage COC, Gaskin G, Pussey CD, Pearson JD: Myeloperoxidase binds to vascular endothelial cells, is recognized by ANCA and can enhance complement dependent cytotoxicity. Adv Exp Med Biol 336: 121–123, 1993
Karlsson K, Marklund SL: Heparin-induced release of superoxide dismutase to human blood plasma. Biochem J 242: 55–59, 1987
Matheson NR, Wong PS, Travis J: Interaction of human α-1-proteinase inhibitor with neutrophil myeloperoxidase. Biochemistry 20: 331–336, 1981
Wasil M, Halliwell B, Hutchison DCS, Baum H: The antioxidant action of human extracellular fluids. Biochem J 243: 219–223, 1987
Avila JL, Convit J: Inhibition of leukocytic lysosomal enzymes by glycosaminoglycans in vitro. Biochem J 160: 129–136, 1975
Pejler G, Maccarana M: Interaction of heparin with rat mast cell protease. J Biol Chem 269: 14451, 1994
Yayon A, Klagsbrun M, Esko DJ, Leder P, Ornitz DM: Cell surface heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 66: 841–848, 1991
Esmon WG, Owen CT: Identification of an endothelial cell factor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78: 2249–2252, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daphna, EM., Michaela, S., Eynat, P. et al. Association of myeloperoxidase with heparin: Oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Mol Cell Biochem 183, 55–61 (1998). https://doi.org/10.1023/A:1006848730927
Issue Date:
DOI: https://doi.org/10.1023/A:1006848730927